Pentax of America Inc appears in FDA device enforcement records from Montvale, New Jersey, as the recalling firm for a group of PENTAX Medical ultrasound endoscope models and the OS-H5 water bottle assembly. The five records share event ID 99782, a September 9, 2026 initiation date, an October 28, 2026 classification date, Class II designation, voluntary firm-initiated status, and letter notification. Each record states the same reason: warnings added to the instructions for use for ultrasound endoscopes and water bottle assembly to ensure deaerated sterile water is in the assembly prior to and during the procedure. The records describe labeling changes; they do not describe removal of devices from the field. [1][2][3][4][5]

Endoscope models named in the enforcement records

Four of the five records cover ultrasound endoscopes. Z-0308-2027 lists model numbers EG-3870UTK and EG-3670URK, with 737 units and multiple UDI-DI codes under all serial numbers. Z-0306-2027 covers model EG36-J10UR at 84 units. Z-0307-2027 covers EG38-J10UT and EG34-J10U at 182 units. Z-0309-2027 covers EG-3270UK at 65 units. Each record carries the product description PENTAX Medical Ultrasound Endoscope and the same reason for recall. [1][3][4][5]

The FDA recall database entries for the ultrasound endoscope carry the Class 2 Device Recall heading, consistent with the Class II classification in the enforcement records. Those database pages identify the product category and the recall type but do not add model-level detail beyond the enforcement entries. [6][7]

Water bottle assembly record

Z-0310-2027 covers the PENTAX Medical Water bottle assembly, model OS-H5, with 2,972 units and four UDI-DI codes under all serial numbers. It shares the event ID, dates, classification, notification method and reason text with the endoscope records, tying the labeling change to both the scopes and the accessory used with them. The FDA recall database also lists a Class 2 Device Recall page for the water bottle assembly. [2][9]

Distribution and regulatory context

All five records describe distribution as worldwide, with US nationwide and international distribution pending, and list the firm address as 3 Paragon Dr, Montvale, NJ 07645-1782. That address is the contact location in the filings, not a verified corporate headquarters. The records do not state customer counts, market share or post-market performance. [1][2][3][4][5]

Separate FDA correspondence from August 21, 2018 addresses PENTAX of America, Inc. at the same Montvale address regarding K182004 for the PENTAX Medical Endoscopic Ultrasound System, under regulation 21 CFR 876.1500, class II, product codes ODG and ITX. That letter documents an earlier premarket submission for an endoscopic ultrasound system and is distinct from the 2026 enforcement records. [10]